23Dec 2023
Dual Antiplatelet Therapy De-Escalation in Stabilized Myocardial Infarction With High Ischemic Risk

Dual Antiplatelet Therapy De-Escalation in Stabilized Myocardial Infarction With High Ischemic Risk

The study, involving 2697 patients with acute myocardial infarction (AMI), explores the efficacy and safety of switching from ticagrelor to clopidogrel in high ischemic risk cases after percutaneous coronary intervention. Among 1371 patients with high ischemic risk, de-escalation to clopidogrel demonstrated no significant difference in ischemic risk compared to ticagrelor-based dual antiplatelet therapy. Bleeding risks were consistent across both high and non-high ischemic risk groups. The findings suggest that the unguided de-escalation strategy with clopidogrel is comparable to ticagrelor-based therapy in stabilized AMI patients, irrespective of high ischemic risk.

  • #cardiology

Like

Save

Share